Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
01 3Polfa Tarchomin
02 1Capital Farma
03 3Accord healthcare
04 6Actavis Inc
05 5Alembic Pharmaceuticals Limited
06 4Alphapharm PTY Ltd
07 2Apotex Inc
08 3Aurobindo Pharma Limited
09 3Avery Pharmaceuticals
10 5Barr Laboratories
11 3Chartwell Pharmaceuticals llc
12 7Cheplapharm Arzneimittel Gmbh
13 12F. Hoffmann-La Roche
14 1Halewood Laboratories Pvt. Ltd
15 4Indo Pharma
16 3Intas Pharmaceuticals
17 2LABORATOIRE RIVA INC.
18 2MS Pharma
19 4Neuraxpharm
20 2ORIFARM GROUP AS
21 5PH HEALTH
22 3PHARMOBEDIENT
23 3PRO DOC LIMITEE
24 7Pharmaco
25 4Pharmaco Distribution
26 10Pharmascience Inc.
27 3Prinston
28 3R Key Enterprises
29 12RELIANCE FORMULATION PVT. LTD
30 4Ram Pharma
31 3Rubicon Research
32 3Sandoz B2B
33 8Sun Pharmaceutical Industries Limited
34 6Teva Pharmaceutical Industries
35 1Vaishali Pharma Ltd
36 3Verve Human Care Laboratories
37 1XL Laboratories Private Limited
38 7Zim Laboratories
39 5Zota Healthcare Ltd
01 4Antic-calc Tablet
02 1Clonazepam 0.5Mg 20 Joined' Oral Use
03 1Clonazepam 2,5Mg/Ml 10Ml Oral Use
04 1Clonazepam 2Mg 20 Joined' Oral Use
05 4DC Granules and Tablets
06 1DRP
07 1INJ
08 4Mouth Dissolving Tablet
09 3OD Tablet
10 1Oral Drop solution
11 1Oral Drops
12 1Oral Solution
13 3Orally Disintegrating Tablet
14 1Solution for Injection
15 8TAB
16 28TABLET
17 25TABLET, ORALLY DISINTEGRATING;ORAL
18 41TABLET;ORAL
19 23Tablet
20 2injection
21 4tablet
22 8Blank
01 27DISCN
02 3Dossier Available
03 13Generic
04 6Originator
05 39RX
06 5Targeted (CDSA IV)
07 73Blank
01 2APO-CLONAZEPAM
02 1CLODAZOL
03 2CLONAM 0,5
04 2CLONAM 2
05 1CLONAPAX MD 0.25
06 1CLONAPAX MD 0.50
07 1CLONAPAX MD 1
08 1CLONAPAX MD 2
09 1CLONAPAX P-10
10 1CLONAPAX P-20
11 1CLONAPAX-0.5
12 1CLONAPAX-1
13 1CLONAPAX-2
14 56CLONAZEPAM
15 3CLOPAM
16 1ESCITAPAX PLUS
17 1ESCITAPAX PLUS - H
18 1ESCITAPAX PLUS - L
19 5KLONOPIN
20 5KLONOPIN RAPIDLY DISINTEGRATING
21 3Otril
22 4PMS-CLONAZEPAM
23 1PMS-CLONAZEPAM TAB 0.5MG
24 1PMS-CLONAZEPAM TAB 1.0MG
25 1PMS-CLONAZEPAM TAB 2MG
26 1PMS-CLONAZEPAM- TAB 0.25MG
27 1PMS-CLONAZEPAM-R
28 1PMS-CLONAZEPAM-R TAB 0.5MG
29 3PRO-CLONAZEPAM
30 2Paxam 0.5
31 2Paxam 2
32 2RIVA-CLONAZEPAM
33 2RIVOTRIL
34 4Rivoram
35 16Rivotril
36 1Rivotril 1mg/ml
37 33Blank
01 11Australia
02 19Canada
03 39India
04 3Italy
05 6Jordan
06 4Norway
07 3Poland
08 10South Africa
09 5Spain
10 66USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Tablet
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
Regulatory Info :
Registration Country : Spain
Brand Name :
Dosage Form : Oral Drop solution
Dosage Strength : 2.5MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 1996-10-31
Application Number : 74869
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 1996-10-31
Application Number : 74869
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 1996-10-31
Application Number : 74869
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 1982-01-01
Application Number : 17533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 1982-01-01
Application Number : 17533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 1982-01-01
Application Number : 17533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.125MG
Packaging :
Approval Date : 1997-04-09
Application Number : 17533
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 1997-04-09
Application Number : 17533
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KLONOPIN RAPIDLY DISINTEGRATING
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-12-23
Application Number : 20813
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 1996-09-10
Application Number : 74569
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 1996-09-10
Application Number : 74569
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONAZEPAM
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 1996-09-10
Application Number : 74569
Regulatory Info : RX
Registration Country : USA
